Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia
Lingmin Song, Wenhao Shen, Heng Zhang, et al.
Bosnian Journal of Basic Medical Sciences (2016) Vol. 16, Iss. 3, pp. 201-208
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Benign prostatic hyperplasia – what do we know?
Conor M. Devlin, Matthew Simms, Norman J. Maitland
BJU International (2020) Vol. 127, Iss. 4, pp. 389-399
Open Access | Times Cited: 178
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
Deli Liu, Jonathan E. Shoag, Daniel Poliak, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 47
Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression
Thea Grindstad, Elin Richardsen, Sigve Andersen, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 46
Protective effect of the hydroethanolic extract of camelthorn (Alhagi maurorum) on benign prostatic hyperplasia induced by testosterone in rats
Fatemeh Hoseinpour, Mohammad Hashemnia, Hadi Cheraghi, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access
Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
Marcello Henrique Araujo Da Silva, Diogo Benchimol de Souza
Research and Reports in Urology (2019) Vol. Volume 11, pp. 1-8
Open Access | Times Cited: 22
The 11β-hydroxyandrostenedione pathway and C11-oxy C21 backdoor pathway are active in benign prostatic hyperplasia yielding 11keto-testosterone and 11keto-progesterone
Therina du Toit, Amanda C. Swart
The Journal of Steroid Biochemistry and Molecular Biology (2019) Vol. 196, pp. 105497-105497
Closed Access | Times Cited: 22
Postnatal separation prevents the development of prenatal stress‐induced anxiety in association with changes in oestrogen receptor and oxytocin immunoreactivity in female mandarin vole (Microtus mandarinus) offspring
Fengqin He, Zijian Wang, Guanlin Guo
European Journal of Neuroscience (2017) Vol. 47, Iss. 1, pp. 95-108
Closed Access | Times Cited: 15
Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia
Bo Chen, Dehong Cao, Zeyu Chen, et al.
Translational Andrology and Urology (2020) Vol. 9, Iss. 2, pp. 322-331
Open Access | Times Cited: 14
Anti-proliferative activities of finasteride in benign prostate epithelial cells require stromal fibroblasts and c-Jun gene
Kai Wang, Song Jin, Dongdong Fan, et al.
PLoS ONE (2017) Vol. 12, Iss. 2, pp. e0172233-e0172233
Open Access | Times Cited: 14
N-Butanol and Aqueous Fractions of Red Maca Methanolic Extract Exerts Opposite Effects on Androgen and Oestrogens Receptors (Alpha and Beta) in Rats with Testosterone-Induced Benign Prostatic Hyperplasia
Diego Fano-Sizgorich, Cinthya Vásquez‐Velásquez, Cynthia Gonzales‐Castañeda, et al.
Evidence-based Complementary and Alternative Medicine (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 13
Prostate-specific antigen, androgen, progesterone and oestrogen receptors in Benign prostatic hyperplasia: human tissues and animal model study
Haohan Wang, Chengcheng Liu, Ziqiang Dong, et al.
The Aging Male (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 1
TILRR (FREM1 isoform 2) is a prognostic biomarker correlated with immune infiltration in breast cancer
Xiaoyi Xu, Wenjing Guo, Shihua Pan, et al.
Aging (2020) Vol. 12, Iss. 19, pp. 19335-19351
Open Access | Times Cited: 10
Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk
Weiqiang Li, Robert J. Klein
Prostate Cancer and Prostatic Diseases (2020) Vol. 24, Iss. 2, pp. 492-498
Closed Access | Times Cited: 10
C11-hydroxy and C11-oxo C19 and C21 Steroids: Pre-Receptor Regulation and Interaction with Androgen and Progesterone Steroid Receptors
Rachelle Gent, Desmaré van Rooyen, Stephen L. Atkin, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 101-101
Open Access | Times Cited: 3
Short‐term exposure to chrysin promotes proliferative responses in the ventral male prostate and female prostate of adult gerbils
Mônica S. Campos, João Paulo Alves Silva, Danilo S. Lima, et al.
International Journal of Experimental Pathology (2019) Vol. 100, Iss. 3, pp. 192-201
Open Access | Times Cited: 8
Immunohistochemical analysis of the impact of ischemic change in benign prostatic hyperplasia
Won Jin Cho, Jung‐Soo Pyo
Pathology - Research and Practice (2019) Vol. 216, Iss. 1, pp. 152694-152694
Closed Access | Times Cited: 8
Modulatory effect of aquaporin 5 on estrogen-induced epithelial-mesenchymal transition in prostate epithelial cells
Yu Fan, Turun Song, Qiang Wei, et al.
Chinese Medical Journal (2020) Vol. 134, Iss. 4, pp. 448-455
Open Access | Times Cited: 7
The effect of acupuncture on oestrogen receptors in rats with benign prostatic hyperplasia
Liang Pan, Shiyu Su, Yuanyuan Li, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2023) Vol. 234, pp. 106402-106402
Open Access | Times Cited: 2
Beneficial Effect of a Multifunctional Polyphytocompound in Experimental Prostatic Hyperplasia in Rats
Makoto Kantah, Birbal Singh, Hala S. Sweed, et al.
Clinical Pharmacology & Biopharmaceutics (2017) Vol. 06, Iss. 02
Open Access | Times Cited: 5
Therapeutic effects of β‐caryophyllene on proliferative disorders and inflammation of the gerbil prostate
Nayara Fernanda da Costa Castro, Fernanda Costa Jubilato, Luiz Henrique Alves Guerra, et al.
The Prostate (2021) Vol. 81, Iss. 12, pp. 812-824
Closed Access | Times Cited: 5
The extract of Celtis choseniana Nakai alleviates testosterone-induced benign prostatic hyperplasia through inhibiting 5α reductase type 2 and the Akt/NF-κB/AR pathway
Geum-Lan Hong, Tae-Won KIM, Hui-Ju Lee, et al.
Chinese Journal of Natural Medicines (2022) Vol. 20, Iss. 7, pp. 518-526
Closed Access | Times Cited: 3
Network pharmacology and experimental validation to explore the pharmacological mechanism of saw palmetto and its core ingredients in benign prostatic hyperplasia treatment
Bo Zhang, Yiying Wang, Kunping Yan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Androgens and benign prostatic hyperplasia
Tristan M. Nicholson, Maritza T. Farrant, Stephanie T. Page
Elsevier eBooks (2024)
Closed Access
Oral exposure of sulpiride promotes the proliferation of Brown‑Norway rat prostates
Chengcheng Zheng, Yongwei Luo, Ying Chen, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 3
Immunoexpression of estrogen receptor-β and progesterone receptor in prostate adenocarcinoma, does it inhibit neoplastic proliferation and invasion?
Namrata Sarin, KinjalN Bera, Shakti Kumar Yadav, et al.
Indian Journal of Pathology and Microbiology (2020) Vol. 63, Iss. 5, pp. 30-30
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top